Search results
Humana reports strong Q1 2024 results, revises full-year guidance | Invezz
Invezz· 4 days agoHumana Inc. (NYSE: HUM) has delivered robust financial results for the first quarter of 2024,...
Decoding Humana Inc (HUM): A Strategic SWOT Insight
GuruFocus.com via Yahoo Finance· 3 days agoHumana Inc (NYSE:HUM) showcases robust revenue growth amidst challenging market conditions. Strategic focus on Medicare Advantage and healthcare services...
Humana warns of tough times ahead for Medicare Advantage
WDRB 41 Louisville News· 3 days agoLouisville-based Humana Inc. warned investors of tough times ahead in the next few years for...
Why Humana Stock Withered on Wednesday
Motley Fool via Yahoo Finance· 4 days agoHumana (NYSE: HUM) stock has not been a favorite of investors this year, and the health insurer's first-quarter earnings report published Wednesday...
Humana (NYSE:HUM) PT Lowered to $381.00
ETF DAILY NEWS· 4 days agoHumana (NYSE:HUM – Get Free Report) had its price objective lowered by research analysts at Jefferies Financial Group from $411.00 to $381.00 in a note issued to investors ...
Humana Inc. (NYSE:HUM) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 days agoHumana Inc. (NYSE:HUM) Q1 2024 Earnings Call Transcript April 24, 2024 Humana Inc. misses on...
Humana Boosts Medicare Advantage Membership 2024 Forecast As Q1 Earnings Performance Exceeds...
Benzinga via Yahoo Finance· 4 days agoWednesday, Humana Inc (NYSE:HUM) posted first-quarter adjusted EPS of $7.23, down from $9.38 a year...
Insurer Humana pulls 2025 profit forecast on disappointing Medicare rates
Reuters via AOL· 4 days ago(Reuters) -Humana withdrew its already downscaled 2025 profit forecast on Wednesday, citing...
Humana withdraws 2025 earnings outlook on unsatisfactory MA rates
Healthcare Dive via Yahoo Finance· 4 days agoDive Brief: Humana has pulled its profit outlook for 2025, citing declining Medicare Advantage...
Humana stock gains after Q1 beat (NYSE:HUM)
Seeking Alpha· 4 days agoHumana (HUM) stock rose after the company reported better-than-expected Q1 2024 financials while keeping its full-year outlook unchanged. Read more here.
